SPOTLIGHT -
Dr. Kozuch on the Evaluation of ctDNA in the CIRCULATE-US Trial in Resected CRC
Peter Kozuch, MD, discusses the phase 2/3 CIRCULATE-US trial evaluating chemotherapy decisions for patients with resected colorectal cancer based on circulating tumor DNA status.
Read More
Dr. Kozuch on the Role of ctDNA Following Surgery in CRC
Peter Kozuch, MD, discusses the role of circulating tumor DNA in colorectal cancer.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
